122 related articles for article (PubMed ID: 7879104)
1. Cytomegalovirus infection induces vascular wall inflammation and doubles arteriosclerotic changes in rat cardiac allografts.
Koskinen P; Lemström K; Bruning H; Daemen M; Bruggeman C; Häyry P
Transplant Proc; 1995 Feb; 27(1):574-5. PubMed ID: 7879104
[No Abstract] [Full Text] [Related]
2. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis.
Koskinen P; Lemström K; Bruggeman C; Lautenschlager I; Häyry P
Am J Pathol; 1994 Jan; 144(1):41-50. PubMed ID: 8291611
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infection accelerates mRNA expression of several smooth muscle cell growth factors in the allograft vascular wall.
Lemström K; Koskinen P; Bruning H; Bruggeman C; Aho P; Häyry P
Transplant Proc; 1995 Feb; 27(1):566-7. PubMed ID: 7879101
[No Abstract] [Full Text] [Related]
4. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.
Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
J Clin Invest; 1993 Aug; 92(2):549-58. PubMed ID: 8394384
[TBL] [Abstract][Full Text] [Related]
5. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection.
Lemström K; Koskinen P; Krogerus L; Daemen M; Bruggeman C; Häyry P
Circulation; 1995 Nov; 92(9):2594-604. PubMed ID: 7586362
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus infection enhances allograft arteriosclerosis in the rat.
Lemström K; Persoons M; Bruggeman C; Ustinov J; Lautenschlager I; Häyry P
Transplant Proc; 1993 Feb; 25(1 Pt 2):1406-7. PubMed ID: 8382862
[No Abstract] [Full Text] [Related]
8. Chronic rejection in experimental cardiac transplantation in a rat model.
Karnovsky MJ; Russell ME; Hancock W; Sayegh MH; Adams DH
Clin Transplant; 1994 Jun; 8(3 Pt 2):308-12. PubMed ID: 8061372
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of accelerated graft atherosclerosis in cardiac transplantation.
Louie HW; Pang M; Lewis W; Drinkwater DC; Laks H
Curr Surg; 1989; 46(6):479-83. PubMed ID: 2620541
[TBL] [Abstract][Full Text] [Related]
10. Experimental cardiac allograft vasculopathy in mice.
Ardehali A; Billingsley A; Laks H; Drinkwater DC; Sorensen TJ; Drake TA
J Heart Lung Transplant; 1993; 12(5):730-5. PubMed ID: 8241210
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of cytomegalovirus infection-associated histologic findings in endomyocardial biopsies of heart allografts.
Koskinen PK; Krogerus LA; Nieminen MS; Mattila SP; Häyry PJ; Lautenschlager IT
J Heart Lung Transplant; 1993; 12(3):343-54. PubMed ID: 8392371
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: efficacy of novel therapeutic approaches.
Rabinovitch M; Molossi S; Clausell N
J Heart Lung Transplant; 1995; 14(6 Pt 2):S116-23. PubMed ID: 8719473
[No Abstract] [Full Text] [Related]
13. Crosstalk of endothelin-1 and platelet-derived growth factor in cardiac allograft arteriosclerosis.
Sihvola RK; Pulkkinen VP; Koskinen PK; Lemström KB
J Am Coll Cardiol; 2002 Feb; 39(4):710-7. PubMed ID: 11849873
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis.
Lemström KB; Aho PT; Bruggeman CA; Häyry PJ
Arterioscler Thromb; 1994 Dec; 14(12):2043-52. PubMed ID: 7981194
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infection and cardiac allograft vasculopathy.
Koskinen PK; Kallio EA; Tikkanen JM; Sihvola RK; Häyry PJ; Lemström KB
Transpl Infect Dis; 1999 Jun; 1(2):115-26. PubMed ID: 11428979
[TBL] [Abstract][Full Text] [Related]
16. Initial endothelial injury and cytomegalovirus infection accelerate the development of allograft arteriosclerosis.
Li F; Grauls G; Yin M; Bruggeman CA
Transplant Proc; 1995 Dec; 27(6):3552-4. PubMed ID: 8540098
[No Abstract] [Full Text] [Related]
17. Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.
Moien-Afshari F; Choy JC; McManus BM; Laher I
J Heart Lung Transplant; 2004 Feb; 23(2):193-203. PubMed ID: 14761767
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat.
Lemström KB; Bruning JH; Bruggeman CA; Koskinen PK; Aho PT; Yilmaz S; Lautenschlager IT; Häyry PJ
Circulation; 1994 Oct; 90(4):1969-78. PubMed ID: 7923687
[TBL] [Abstract][Full Text] [Related]
19. Experimental atherosclerosis in rat and rabbit cardiac allografts.
Laden AM
Arch Pathol; 1972 Mar; 93(3):240-5. PubMed ID: 4551496
[No Abstract] [Full Text] [Related]
20. VEGFR-1 and -2 regulate inflammation, myocardial angiogenesis, and arteriosclerosis in chronically rejecting cardiac allografts.
Raisky O; Nykänen AI; Krebs R; Hollmén M; Keränen MA; Tikkanen JM; Sihvola R; Alhonen L; Salven P; Wu Y; Hicklin DJ; Alitalo K; Koskinen PK; Lemström KB
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):819-25. PubMed ID: 17290032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
